New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
09:00 EDTLQDT, FWM, ARIA, ELON, ONNN, ANR, ATVI, GTAT, EXPE, OUTR, LNKD, AAPLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Expedia (EXPE), up 12.5%... Activision Blizzard (AtVI), up 8%... Liquidity Services (LQDT), up 12%... ON Semiconductor (ONNN), up 6%. ALSO HIGHER: Apple (AAPL), up nearly 2% after CEO Tim Cook told the WSJ that the company has repurchased $14B worth of stock in the two week since its quarterly earnings report... Outerwall (OUTR), up 10% after earnings report, $350M buyback through modified Dutch auction tender offer, management changes... Alpha Natural (ANR), up 2% after upgraded to Neutral from Sell at Citigroup... ARIAD Pharmaceuticals (ARIA), up 6% after Reuters reports that Sarissa Capital, run by Carl Icahn's former healthcare head, is seeking at least two seats on the company's board... GT Advanced (GTAT), up 6% after 9to5Mac said the company is preparing to manufacture sapphire displays for Apple. DOWN AFTER EARNINGS: LinkedIn (LNKD), down 6%... Echelon (ELON), down 18%. ALSO LOWER: Fairway Group (FWM), down 23% after weaker than expected Q3 results, retirement of CEO, downgrades by at least five research firms... iRobot (IRBT), down 2% following downgrade to Underweight at JPMorgan.
News For LNKD;AAPL;EXPE;ATVI;OUTR;GTAT;ONNN;ANR;ARIA;FWM;ELON;LQDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 16, 2015
11:17 EDTAAPLApple July weekly volatility elevated into Q3 and outlook
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:34 EDTAAPLSt. Jude Medical receives FDA approval for spinal cord stimulation trial system
St. Jude Medical (STJ) announced it received FDA approval of the Invisible Trial System. The system, which received CE Mark in June 2015, is fully wireless and leverages Apple (AAPL) technology for both the patient and physician controllers. The system is designed to provide patients a more improved and discreet spinal cord stimulation, or SCS, trial experience. "Patients undergoing SCS trials consistently tell us about challenges they find in navigating the SCS trial system, from programming the device, to discomfort from the programming cables, to management of both issues. These hindrances may impede the integration of the technology into their daily activities, which shifts their focus away from evaluating the effectiveness of SCS therapy,” said pain specialist Dr. Jason E. Pope, president of Summit Pain Alliance in Santa Rosa, California. “By providing a discreet trial system, St. Jude Medical will help patients focus more on their potential pain relief and functional improvements, and less about the burdens common to traditional trial systems.”
08:18 EDTAAPLSeveral stocks attractive following Intel results, says JMP Securities
For investors looking to take advantage of the sentiment shift the Intel (INTC) results could mean for the group and stronger demand due to seasonality and the Windows 10 launch, JMP Securities recommends Nvidia (NVDA) and Micron (MU). The firm says that both stocks have more attractive valuations and "more strategic roadmaps" than Intel. It also recommends Apple (AAPL) and Qualcomm (QCOM) as more attractive and secure dividend growth plays.
07:22 EDTAAPLiPhone average selling prices may be underestimated by Street, says UBS
Subscribe for More Information
07:19 EDTAAPLApple Q3 iPhone estimates raised at Stifel
Subscribe for More Information
06:58 EDTAAPLApple applies for patent for wireless devices with solar cells
Subscribe for More Information
06:46 EDTAAPLApple Watch to roll out in New Zealand July 31, AppleInsider reports
Subscribe for More Information
July 15, 2015
19:03 EDTANROn The Fly: After Hours Movers
Subscribe for More Information
18:59 EDTANRAlpha Natural in talks for financing of possible bankruptcy filing, WSJ says
Alpha Natural is engaging in discussions for financing for a possible bankruptcy filing, reports the Wall Street Journal, citing people familiar with the matter. The filing could come early next month, the Journal adds. Reference Link
16:00 EDTAAPLOptions Update; July 15, 2015
Subscribe for More Information
14:26 EDTLNKDLinkedIn heads higher after Barclays ups rating ahead of earnings
Subscribe for More Information
12:38 EDTAAPLGundlach says out of Apple position
Subscribe for More Information
11:01 EDTAAPLApple introduces new iPod touch, unveils new colors for iPod models
Subscribe for More Information
10:01 EDTLNKDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AGCO (AGCO) upgraded to Market Perform from Underperform at Wells Fargo... Anglo American (AAUKY) upgraded to Outperform from Neutral at Credit Suisse... Avis Budget (CAR) upgraded to Buy from Hold at Deutsche Bank... Brookfield Renewable (BEP) upgraded to Neutral from Underperform at Credit Suisse... CSX (CSX) upgraded to Outperform from Sector Perform at RBC Capital... Centene (CNC) upgraded to Buy from Hold at Jefferies... Commerce Bancshares (CBSH) upgraded to Market Perform at Raymond James... Entegris (ENTG) upgraded to Buy at Craig-Hallum... Guess (GES) upgraded to Market Perform from Underperform at Telsey Advisory... Hertz (HTZ) upgraded to Buy from Hold at Deutsche Bank... Iberdrola (IBDRY) upgraded to Buy from Hold at Societe Generale... Liberty Global (LBTYA) upgraded to Conviction Buy from Buy at Goldman... LinkedIn (LNKD) upgraded to Overweight from Equal Weight at Barclays... Lonmin (LNMIY) upgraded to Neutral from Sell at Goldman... Navient (NAVI) upgraded to Overweight from Equal Weight at Barclays... NetApp (NTAP) upgraded to Sector Weight from Underweight at Pacific Crest... Omnicom (OMC) upgraded to Outperform from Market Perform at Wells Fargo... PTC Therapeutics (PTCT) upgraded to Overweight from Neutral at JPMorgan... Panera Bread (PNRA) upgraded to Overweight from Underweight at Piper Jaffray... Primerica (PRI) upgraded to Strong Buy from Market Perform at Raymond James... Sands China (SCHYY) upgraded to Overweight from Equal Weight at Barclays... Seagate (STX) upgraded to Buy at Craig-Hallum... Western Digital (WDC) upgraded to Buy from Hold at Craig-Hallum... Wolseley (WOSYY) upgraded to Overweight from Neutral at JPMorgan.
09:53 EDTAAPLHSBC UK says Apple Pay support coming within 2 weeks, Apple Insider says
HSBC UK (HSBC) said that Apple Pay (AAPL) support is in its final testing and availability will be coming within two weeks, reports Apple Insider. An HSBC spokesperson said, "We are excited to be one of a small number of Apple Pay launch partners. We have been working closely with Apple and are now properly reviewing and testing our systems before launching in two weeks." Reference Link
09:32 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL FB BAC RCPT MU YUM NFLX CELG
06:39 EDTAAPLApple to release new iPod touch, 9to5Mac reports
Subscribe for More Information
06:33 EDTAAPLApple 'in touch' with Iranian distributors to sell products there, WSJ reports
Subscribe for More Information
05:44 EDTLNKDLinkedIn upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Paul Vogel upgraded LinkedIn to Overweight and raised his price target for shares to $250 from $225. Shares of the professional social network closed yesterday up 60c to $213.93. Expectations have been reset following LinkedIn's weaker than expected Q1 results, and estimates for the back half of 2015 have potential upside, Vogel tells investors this morning in a research note. The analyst views the Lynda acquisition guidance as conservative and is more positive on the company's Sales Navigator opportunity following his survey work. He views the issues hurting LinkedIn's Q1 results as transitory in nature and recommends buying the stock into the back half of the year.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use